The GBp 1347 support, currently tested, should allow GlaxoSmithKline to rally again.

The firm high profitability allows it to offer a good yield, nearing the 6%. The present share quote displays a + 12% potential to reach the consensus average target price.

Graphically, the trend is neutral in the mid-term and bearish in the short term. This latter brought back the stock on significant support area in daily data as well as in weekly data. Moreover, indicators shows an oversold situation.

Consequently, active investors could buy the share right now while targeting a reversal toward the GBp 1464.5 pivot point. A stop loss order should be set at GBp 1313, in case of further correction.